🇺🇸 FDA
Patent

US 7122579

Eye treatments using synthetic thyroid hormone compositions

granted A61KA61K31/195A61K45/06

Quick answer

US patent 7122579 (Eye treatments using synthetic thyroid hormone compositions) held by The Regents of the University of California expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/195, A61K45/06, A61P, A61P27/06